Assessing Whether Oncolytics Biotech, Inc (NASDAQ: ONCY) Is Over- Or Undervalued
Oncolytics Biotech, Inc (ONCY) concluded trading on Wednesday at a closing price of $0.82, with 32.23 million shares of worth about $26.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -23.36% during that period and on January 15, 2025 the price saw a […]
